It is becoming recognized that an emphasis on the prevention of breast cancer is needed to reduce breast cancer morbidity and mortality. The results of epidemiology studies indicate that diet has a profound influence on breast cancer risk. The long term objectives of this research are to identify dietary changes that humans might make to reduce the risk for breast cancer and to identify biomarkers that might indicate that risk for breast cancer has been reduced. One feasible change may be by altering the type of fat consumed in the diet. Consumption of omega 3 fatty acids (FAs) is usually associated with a lower incidence of breast cancer whereas exposure to high omega 6 fatty acids during gestation and lactation has been shown to increase the future incidence of mammary cancer in mice. We hypothesize that when compared to a diet with a low ratio of n-3/n-6 (high n-6 diet) FAs, maternal consumption of a diet with a high ratio of n-3/n-6 FAs (high n-3 diet) during gestation and lactation of the offspring will reduce the risk for mammary cancer in female offspring via alteration in exposure of the offspring to lower prostaglandin ?2 and estrogen during early development of the mammary gland. A transgenic mouse model that is expected to develop mammary gland cancer by 6 months of age will be used in this study. We will assess whether exposure to modest amounts of omega 3 fatty acids during gestation and lactation and/or throughout life can delay or prevent the occurrence of mammary cancer. Breeding females will be fed one of two diets containing either a high percentage of omega 6 or a high percentage of omega 3 fatty acids and to modification of PGE2. At weaning, female offspring will be randomized to the two diets and followed for mammary cancer development. Tumorigenesis will be assessed up to eight months of age by morphological analyses. Mice will be euthanized at one month intervals to track the development of cancer in the mammary glands and for biochemical analyses. At weaning and at 4 months of age, gene expression in the mammary glands will be assessed by microarray analyses. This will allow us to determine whether expression of genes important to breast cancer development is altered by the omega 3 diet in a manner that would indicate reduction in risk for mammary gland cancer. These changes may make useful biomarkers for future clinical trials. Normal mice will also be exposed to omega 3 fatty acids to ascertain that the observed effects can occur in normal animals and are not due to some unknown interaction between the transgene and the diet. The results from this study: 1) will allow us to determine if omega 3 fatty acids can delay mammary cancer in this mouse model, 2) will demonstrate the effect of exposure to omega 3 fatty acids during gestation and lactation, 3) may identify putative biomarkers of risk that will be useful for future human breast cancer prevention studies and 4) could lead to human dietary recommendations for reduction in risk for breast cancer. ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
3R01CA114018-02S1
Application #
7684306
Study Section
Chemo/Dietary Prevention Study Section (CDP)
Program Officer
Ogunbiyi, Peter
Project Start
2007-09-14
Project End
2011-08-31
Budget Start
2008-09-01
Budget End
2009-08-31
Support Year
2
Fiscal Year
2008
Total Cost
$40,886
Indirect Cost
Name
Marshall University
Department
Biochemistry
Type
Schools of Medicine
DUNS #
036156615
City
Huntington
State
WV
Country
United States
Zip Code
25701
Hardman, W Elaine (2014) Diet components can suppress inflammation and reduce cancer risk. Nutr Res Pract 8:233-40
Hardman, W Elaine (2014) Walnuts have potential for cancer prevention and treatment in mice. J Nutr 144:555S-560S
Fahrmann, Johannes F; Hardman, W Elaine (2013) Omega 3 fatty acids increase the chemo-sensitivity of B-CLL-derived cell lines EHEB and MEC-2 and of B-PLL-derived cell line JVM-2 to anti-cancer drugs doxorubicin, vincristine and fludarabine. Lipids Health Dis 12:36
De Carlo, Flavia; Witte, Theodore R; Hardman, W Elaine et al. (2013) Omega-3 eicosapentaenoic acid decreases CD133 colon cancer stem-like cell marker expression while increasing sensitivity to chemotherapy. PLoS One 8:e69760
Fahrmann, Johannes F; Ballester, Oscar F; Ballester, Gabriela et al. (2013) Inhibition of nuclear factor kappa B activation in early-stage chronic lymphocytic leukemia by omega-3 fatty acids. Cancer Invest 31:24-38
Akinsete, Juliana A; Ion, Gabriela; Witte, Theodore R et al. (2012) Consumption of high ω-3 fatty acid diet suppressed prostate tumorigenesis in C3(1) Tag mice. Carcinogenesis 33:140-8
Hardman, W Elaine; Ion, Gabriela; Akinsete, Juliana A et al. (2011) Dietary walnut suppressed mammary gland tumorigenesis in the C(3)1 TAg mouse. Nutr Cancer 63:960-70
Varney, Melinda E; Buchanan, James T; Dementieva, Yulia et al. (2011) A high omega-3 fatty acid diet has different effects on early and late stage myeloid progenitors. Lipids 46:47-57
Ion, Gabriela; Fazio, Kayla; Akinsete, Juliana A et al. (2011) Effects of canola and corn oil mimetic on Jurkat cells. Lipids Health Dis 10:90
Varney, Melinda E; Hardman, W Elaine; Sollars, Vincent E (2009) Omega 3 fatty acids reduce myeloid progenitor cell frequency in the bone marrow of mice and promote progenitor cell differentiation. Lipids Health Dis 8:9